Radioactive iodine (iodine-131) therapy is indicated for the management of hyperfunctioning thyroid disease and thyroid cancer.

**FDA Approved**

- Graves disease

- Toxic adenoma

- Toxic multinodular goiter

- Non-toxic multinodular goiter

- Well-differentiated thyroidÂ carcinoma

Radioactive iodine diagnostic use can differentiate between the different hyper or hypo-functioning thyroid diseases. This differentiation occurs by measuring the uptake of radioactive iodine in the thyroid after 24-hours.

**Increased RAIU**

- Graves disease

- Toxic multinodular goiter

- Thyroid adenoma

**Decreased RAIU**

- Subacute thyroiditis

- Painless thyroiditis

- Iodine-induced hyperthyroidism

- Factitious hyperthyroidism